ARTICLE | Clinical News
Pharmacia begins Phase III
March 16, 2001 8:00 AM UTC
PHA began an international, 1,300-patient Phase III trial of semaxanib (SU5416) in combination with fluorouracil (5-FU) and leucovorin and PHA's Camptosar irinotecan to treat advanced colorectal cance...